Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood
- Technische Universität Dresden, Germany
- University Clinic Carl Gustav Carus, Technische Universität Dresden, Germany
- University of Glasgow, United Kingdom
- Karolinska Institutet, Sweden
- University of Cambridge, United Kingdom
Abstract
Blood is arguably the most important bodily fluid and its analysis provides crucial health status information. A first routine measure to narrow down diagnosis in clinical practice is the differential blood count, determining the frequency of all major blood cells. What is lacking to advance initial blood diagnostics is an unbiased and quick functional assessment of blood that can narrow down the diagnosis and generate specific hypotheses. To address this need, we introduce the continuous, cell-by-cell morpho-rheological (MORE) analysis of diluted whole blood, without labeling, enrichment or separation, at rates of 1,000 cells/sec. In a drop of blood we can identify all major blood cells and characterize their pathological changes in several disease conditions in vitro and in patient samples. This approach takes previous results of mechanical studies on specifically isolated blood cells to the level of application directly in blood and adds a functional dimension to conventional blood analysis.
Data availability
-
Data from: Detection of human disease conditions by single-cell morpho-rheological phenotyping of whole bloodAvailable at Dryad Digital Repository under a CC0 Public Domain Dedication.
Article and author information
Author details
Funding
Alexander von Humboldt-Stiftung (Alexander von Humboldt Professorship)
- Jochen Guck
National Institute for Health Research (Cambridge Biomedical Research Centre)
- Edwin R Chilvers
GlaxoSmithKline (noncommercial grant)
- Edwin R Chilvers
Seventh Framework Programme (ERC Starting Grant #282060)
- Jochen Guck
Deutsche Forschungsgemeinschaft (TRR83 and SFB655)
- Ünal Coskun
- Martin Bornhäuser
Seventh Framework Programme (ITN)
- Lisa Ranford-Cartwright
- Birgitta Henriques Normark
- Jochen Guck
Bundesministerium für Bildung und Forschung (German Center for Diabetes Research (DZD e.V.))
- Ünal Coskun
Sächsisches Staatsministerium für Wissenschaft und Kunst (TG70 AZ 4-7531.60/29/45)
- Oliver Otto
- Jochen Guck
Tour der Hoffnung (noncommercial grant)
- Julia Stächele
Sonnenstrahl e.V. Dresden (noncommercial grant)
- Meinolf Suttorp
Center for Regenerative Therapies Dresden (Seed grant FZ 111)
- Jochen Guck
Technische Universität Dresden (Support the Best Program)
- Reinhard Berner
- Jochen Guck
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The work involved measurements of human blood samples. All studies complied with the Declaration of Helsinki and involved written informed consent from all participants or their legal guardians. Ethics for experiments with human blood were approved by the ethics committee of the Technische Universität Dresden (EK89032013, EK458102015), and for human blood and LPS inhalation in healthy volunteers by the East of England, Cambridge Central ethics committee (Study No. 06/Q0108/281 and ClinicalTrialReference NCT02551614).
Copyright
© 2018, Toepfner et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 7,397
- views
-
- 917
- downloads
-
- 136
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood
eLife 7:e29213.
https://doi.org/10.7554/eLife.29213
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
-
- Structural Biology and Molecular Biophysics
The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.
